Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Invested Capital: 2010-2024

Historic Invested Capital for Sunshine Biopharma (SBFM) over the last 12 years, with Dec 2024 value amounting to $23.5 million.

  • Sunshine Biopharma's Invested Capital fell 3.35% to $24.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.2 million, marking a year-over-year decrease of 3.35%. This contributed to the annual value of $23.5 million for FY2024, which is 10.81% up from last year.
  • Latest data reveals that Sunshine Biopharma reported Invested Capital of $23.5 million as of FY2024, which was up 10.81% from $21.2 million recorded in FY2023.
  • Sunshine Biopharma's 5-year Invested Capital high stood at $23.5 million for FY2024, and its period low was -$5,831 during FY2020.
  • In the last 3 years, Sunshine Biopharma's Invested Capital had a median value of $21.6 million in 2022 and averaged $22.1 million.
  • As far as peak fluctuations go, Sunshine Biopharma's Invested Capital spiked by 10,117.97% in 2022, and later decreased by 1.94% in 2023.
  • Over the past 5 years, Sunshine Biopharma's Invested Capital (Yearly) stood at -$5,831 in 2020, then skyrocketed by 3,729.94% to $211,662 in 2021, then spiked by 10,117.97% to $21.6 million in 2022, then dropped by 1.94% to $21.2 million in 2023, then increased by 10.81% to $23.5 million in 2024.